DARU Journal of Pharmaceutical Sciences
| Discipline | Pharmaceutical sciences |
|---|---|
| Language | English |
| Edited by | Mohammad Abdollahi |
| Publication details | |
| History | Since 1990 |
| Publisher | Springer Science+Business Media on behalf of Tehran University of Medical Sciences (Iran) |
| Frequency | Monthly |
| Hybrid | |
| 2.1 (2024) | |
| Standard abbreviations | |
| ISO 4 | DARU J. Pharm. Sci. |
| Indexing | |
| ISSN | 1560-8115 (print) 2008-2231 (web) |
| OCLC no. | 61283828 |
| Links | |
DARU Journal of Pharmaceutical Sciences is an hybrid open-access peer-reviewed medical journal that was established in 1990 in Iran. It covers all aspects of the pharmaceutical sciences. The editor-in-chief is Mohammad Abdollahi. From 2018 the journal is published by Springer Science+Business Media on behalf of Tehran University of Medical Sciences.[1]
History
The journal was established as a Persian language journal in 1990. English abstracts were included in 1995, and the language changed to English in 1999. In 2012, the journal moved to open access with BioMed Central,[2] which lasted until 2017.[1]
Abstracting and indexing
The journal is indexed and abstracted in:
According to the Journal Citation Reports, the journal has a 2024 impact factor of 2.1.[3]
Individual papers
On November 2025 Retraction Watch reported that the journal published a paper co-authored by the editor-in-chief that contained fabricated references, repetitive language and other characteristics of AI generated text.[4] Springer Nature flaged the paper on unespecific concerns.[5]
See also
References
- ^ a b "Aims and scope". DARU Journal of Pharmaceutical Sciences. Retrieved 16 November 2025.
- ^ Abdollahi, M (2012). "DARU Journal of Pharmaceutical Sciences; The 2012 report of Editor-in-Chief". DARU J Pharm Sci. 20 (1) 1. doi:10.1186/1560-8115-20-1. PMC 3514538. PMID 23226110.
- ^ "DARU Journal of Pharmaceutical Sciences". 2024 Journal Citation Reports (Science ed.). Clarivate. 2025 – via Web of Science.
- ^ Orrall, Avery; Travis, Kate (2025-11-21). "Springer Nature flags paper with fabricated reference to article (not) written by our cofounder". Retraction Watch. Archived from the original on 2025-11-25. Retrieved 2025-11-25.
- ^ Aristidis Tsatsakis; Michael Aschner; Dimosthenis Sarigiannis; et al. (13 November 2025). "An expert criticism on post-publication peer review platforms: the case of pubpeer". DARU Journal of Pharmaceutical Sciences. 34 (1). doi:10.1007/S40199-025-00580-Z. ISSN 1560-8115. Wikidata Q137000226.